InvestorsHub Logo
Followers 230
Posts 21508
Boards Moderated 2
Alias Born 08/03/2006

Re: micromillionaire post# 8249

Friday, 03/05/2021 6:26:19 AM

Friday, March 05, 2021 6:26:19 AM

Post# of 8470
Current cash runway provides funding into 2023 and ability to fully fund Phase 1b/2a clinical trial of SYN-004 and Phase 1 safety studies of SYN-020 intestinal alkaline phosphatase ("IAP") program

Upcoming milestones:

Expect to begin dosing patients in the first antibiotic cohort of the SYN-004 Phase 1b/2a clinical trial during Q1 2021; A topline data readout of the first antibiotic cohort is expected during Q4 2021

Expect to commence first Phase 1 single-ascending-dose study ("SAD") of SYN-020 during Q2 2021; Topline data anticipated during Q3 2021

Expect to commence second Phase 1 multiple-ascending-dose ("MAD") study of SYN-020 during Q3 2021; Topline data anticipated during Q2 2022

https://finance.yahoo.com/news/synthetic-biologics-reports-2020-end-211000922.html

I started buying again yesterday myself!!


Do your research! Play the TA. All posts are my opinion.
Is fundamental trading dead?

"We hope not." Richard Dennis

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TOVX News